MRNA (Moderna) FFO


MRNA Moderna Inc MRNA
58 GF Score
Price $67.27
GF Value $22.94
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Moderna FFO?

FFO (Funds from operations) only applies to REITs.

MRNA
58GF Score
Moderna Inc MRNA
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Moderna (MRNA) Overvalued in 2026?

Based on GuruFocus' analysis, Moderna stock appears to be overvalued. The current stock price of $67.27 is trading 193.2% above its estimated GF Value™ of $22.94. GuruFocus considers Moderna to be Significantly Overvalued.

Key valuation signals for MRNA:

  • FFO:
  • GF Value™: $22.94 vs. price of $67.27 (193.2% above fair value)
  • GF Score™: 58/100 with 7 warning signs

No single metric tells the full story. See the MRNA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Moderna Business Description

Address 325 Binney Street, Cambridge, MA, USA, 02142
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
58GF Score

Get the complete analysis for MRNA

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$67.27
Price
$22.94
GF Value